HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William C Bowen Selected Research

F-actin-binding proteins

1/2022Lymphocyte-Specific Protein-1 Suppresses Xenobiotic-Induced Constitutive Androstane Receptor and Subsequent Yes-Associated Protein-Activated Hepatocyte Proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William C Bowen Research Topics

Disease

5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2008
4Hepatomegaly
01/2019 - 12/2008
2Hyperplasia
01/2019 - 02/2011
2Liver Neoplasms (Liver Cancer)
01/2013 - 05/2010
2Carcinogenesis
05/2010 - 04/2002
1Hypertrophy
01/2022
1Fatty Liver
11/2019
1Fibrosis (Cirrhosis)
11/2019
1Non-alcoholic Fatty Liver Disease
11/2019
1Liver Failure
10/2018
1Fibrosarcoma
01/2018
1Ascites
11/2016
1Acute-Phase Reaction
01/2014
1Glioblastoma (Glioblastoma Multiforme)
07/2013
1Liver Diseases (Liver Disease)
12/2010
1Neoplasms (Cancer)
05/2010
1Infections
08/2009
1Hepatitis
04/2007
1Necrosis
04/2007
1Inflammation (Inflammations)
04/2007
1Alagille Syndrome (Alagille-Watson Syndrome)
04/2004

Drug/Important Bio-Agent (IBA)

4Benzene (Benzole)IBA
01/2022 - 02/2011
41,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA
01/2022 - 02/2011
4Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2013
3Constitutive Androstane ReceptorIBA
01/2022 - 02/2011
3MitogensIBA
01/2022 - 08/2011
3ErbB Receptors (EGF Receptor)IBA
11/2019 - 10/2018
3integrin-linked kinaseIBA
02/2011 - 04/2007
2Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2019
2XenobioticsIBA
01/2022 - 08/2011
2Small Interfering RNA (siRNA)IBA
01/2018 - 02/2015
1F-actin-binding proteinsIBA
01/2022
1LigandsIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1PPAR gammaIBA
11/2019
1Canertinib (CI 1033)IBA
11/2019
1CarbohydratesIBA
11/2019
1Carrier Proteins (Binding Protein)IBA
11/2019
1ElementsIBA
11/2019
1Glucose (Dextrose)FDA LinkGeneric
11/2019
1SterolsIBA
11/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2019
1Hepatocyte Nuclear Factor 4IBA
11/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019
1tyrosine receptor (receptor, tyrosine)IBA
01/2019
1CytokinesIBA
01/2019
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2018
1AmmoniaIBA
11/2016
1Messenger RNA (mRNA)IBA
02/2015
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2014
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2014
1Biological ProductsIBA
01/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1GlypicansIBA
08/2011
1Phenobarbital (Luminal)FDA Link
08/2011
1IntegrinsIBA
02/2011
1DAPMIBA
12/2010
1Transforming Growth Factor beta (TGF-beta)IBA
08/2010
1beta CateninIBA
05/2010
1TetraspaninsIBA
08/2009
1DNA (Deoxyribonucleic Acid)IBA
08/2008
1Cre recombinaseIBA
04/2007
1Jagged-1 ProteinIBA
04/2004
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2002

Therapy/Procedure

5Hepatectomy
01/2022 - 02/2015
1Ligation
12/2010